Lives unaffected by cystic fibrosis

1 August 2022

Conquer Cystic Fibrosis Lung Health Transplant Grant 2022

Cystic Fibrosis Australia (CFA) is pleased to announce the Conquer Cystic Fibrosis (Conquer CF) Lung Health Transplant Grant. This grant is looking for ‘big thinkers’ with great innovative ideas who will make a difference through research to the CF community.  It is open to post-doctoral researchers, scientists, clinicians, medical practitioners, nurses and allied health currently working in the area of cystic fibrosis (CF) or proposing to work in CF research in the Lung Health Transplant field.  Lung health transplant is defined here to include any aspect of CF health relating to lung pre-transplant, transplant process or post-transplant issues.  The researchers will have completed their studies in CF, organ transplant or a related area within the past ten years.

The Conquer CF Lung Health Transplant Grant will allow a CF researcher to explore novel concepts at the initial feasibility stage. Innovative applications relating to lung health transplant aspects of CF are encouraged, even those lacking pilot data. The grant aims to allow the researcher to generate sufficient data within the one-year grant period to be in a position to apply for additional support from an appropriate funding body to continue the research.

The recipients of the Conquer CF Lung Health Transplant Grant are required to provide progress reports on their research to CFA every six months. In addition, and where appropriate, the recipient will be asked to make a presentation at a CFA conference (held every two years) in Australia.

The maximum amount awarded for the Conquer CF Lung Health Transplant Grant will be $50,000. The actual amount provided will be subject to approval of the applicant’s budget.

Applications must be received no later than 5pm AEST on Friday, 2nd September 2022.

Conquer Cystic Fibrosis is a volunteer-run charity founded and driven by West Australian parents of children with the disease. Its primary aim is to fund CF research which will decrease suffering and increase the life span of people with CF.